Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
2014
|
| In: |
Blood
Year: 2014, Jahrgang: 124, Heft: 21 |
| ISSN: | 1528-0020 |
| Schlagworte: | |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://ashpublications.org/blood/article/124/21/302/96592/Final-Results-for-the-1703-Phase-1b-2-Study-of
|
| Verfasserangaben: | Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Facon, Ravi Vij, Darrell White, Donna E. Reece, Lotfi Benboubker, Jeffrey Zonder, L. Claire Tsao, Kenneth C. Anderson, Eric Bleickardt, Anil K. Singhal, Sagar Lonial |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1505236282 | ||
| 003 | DE-627 | ||
| 005 | 20241002090106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 150709s2014 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)1505236282 | ||
| 035 | |a (DE-576)435236288 | ||
| 035 | |a (DE-599)BSZ435236288 | ||
| 035 | |a (OCoLC)1340697191 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma |c Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Facon, Ravi Vij, Darrell White, Donna E. Reece, Lotfi Benboubker, Jeffrey Zonder, L. Claire Tsao, Kenneth C. Anderson, Eric Bleickardt, Anil K. Singhal, Sagar Lonial |
| 264 | 1 | |c 2014 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.07.2015 | ||
| 655 | 7 | |a Konferenzschrift |0 (DE-588)1071861417 |0 (DE-627)826484824 |0 (DE-576)433375485 |2 gnd-content | |
| 700 | 1 | |a Richardson, Paul G. |0 (DE-588)1073660222 |0 (DE-627)829311114 |0 (DE-576)435237594 |4 oth | |
| 700 | 1 | |a Raab, Marc-Steffen |d 1973- |0 (DE-588)124052460 |0 (DE-627)706520998 |0 (DE-576)293998027 |4 oth | |
| 773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014,21) Artikel-Nr. 74278, 1 S. |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma |
| 773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g extent:1 |a Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma |
| 856 | 4 | 0 | |u https://ashpublications.org/blood/article/124/21/302/96592/Final-Results-for-the-1703-Phase-1b-2-Study-of |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20150709 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 2014 | ||
| 998 | |g 124052460 |a Raab, Marc-Steffen |m 124052460:Raab, Marc-Steffen |d 910000 |d 910100 |e 910000PR124052460 |e 910100PR124052460 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 999 | |a KXP-PPN1505236282 |e 2848427914 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma","title_sort":"Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma"}],"note":["Gesehen am 09.07.2015"],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"2014"}],"id":{"eki":["1505236282"]},"recId":"1505236282","relHost":[{"language":["eng"],"part":{"year":"2014","volume":"124","text":"124(2014,21) Artikel-Nr. 74278, 1 S.","issue":"21","extent":"1"},"titleAlt":[{"title":"Blood online"}],"corporate":[{"display":"American Society of Hematology","role":"isb"}],"recId":"266886647","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]},"title":[{"title":"Blood","subtitle":"journal of the American Society of Hematology","title_sort":"Blood"}],"note":["Gesehen am 21.04.2023"],"pubHistory":["1.1946 -"],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946","dateIssuedDisp":"1946-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myelomaBlood"}],"physDesc":[{"extent":"1 S."}],"name":{"displayForm":["Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Facon, Ravi Vij, Darrell White, Donna E. Reece, Lotfi Benboubker, Jeffrey Zonder, L. Claire Tsao, Kenneth C. Anderson, Eric Bleickardt, Anil K. Singhal, Sagar Lonial"]},"person":[{"family":"Richardson","display":"Richardson, Paul G.","role":"oth","given":"Paul G."},{"display":"Raab, Marc-Steffen","family":"Raab","role":"oth","given":"Marc-Steffen"}],"language":["eng"]} | ||
| SRT | |a FINALRESUL2014 | ||